financetom
Business
financetom
/
Business
/
Goldman Sachs appoints Mark Davis to run Australian equities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs appoints Mark Davis to run Australian equities
Jun 25, 2024 5:35 PM

June 26 (Reuters) - Goldman Sachs ( GS ) said on

Wednesday it has appointed former Credit Suisse executive Mark

Davis as managing director and head of its Australian and New

Zealand Equities division.

Davis is also set to become a member of Goldman Sachs' ( GS )

Australia and New Zealand Operating Committee, the Wall Street

giant mentioned in its statement, adding that he would work

closely with regional leadership to further the client

franchise.

Prior to his latest appointment, Davis had served as the

managing director and head of Global Markets Equities Australia

at Credit Suisse in Sydney, and was among the top executives at

Western Union Australasia.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet's YouTube Trails TikTok in Global Video Revenue, Omdia Says
Alphabet's YouTube Trails TikTok in Global Video Revenue, Omdia Says
Jan 21, 2025
10:25 AM EST, 01/21/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) YouTube ( GOOG ) had a global advertising revenue of $33.3 billion in 2024 compared with TikTok's global video revenues of $63.3 billion, Omdia reported Tuesday. In 2024, TikTok crossed 1.9 billion monthly active users globally, including 145 million monthly active users in the US, with about $8 billion advertising...
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing
Jan 21, 2025
InMed Pharmaceuticals Inc ( INM ) shares are trading higher by 22.6% to $6.05 during Tuesday’s session after the company announced that INM-901 reduced Alzheimer’s-related inflammation in a preclinical study. What To Know: The study revealed a significant reduction in markers of neuroinflammation, a key driver of Alzheimer's progression. Treatment with INM-901 led to a dose-dependent decrease in pro-inflammatory cytokines...
Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing
Guardant Health Gets Medicare Coverage for Guardant Reveal in CRC Surveillance Testing
Jan 21, 2025
10:26 AM EST, 01/21/2025 (MT Newswires) -- Guardant Health ( GH ) said Tuesday that Palmetto GBA has granted coverage for the Guardant Reveal test to monitor for disease recurrence in colorectal cancer patients after curative intent therapy, expanding from the prior coverage in the early post-surgical setting only. Palmetto is a Medicare administrative contractor that administers the Molecular Diagnostics...
Prologis beats core FFO estimates on improving warehouse demand
Prologis beats core FFO estimates on improving warehouse demand
Jan 21, 2025
Jan 21 (Reuters) - Real estate investment trust (REIT) Prologis ( PLD ) beat Wall Street expectations for fourth-quarter core funds from operations (FFO), helped by improving demand for its warehousing spaces and sale of a data center. Shares of the warehouse-focused REIT were up 3.3% in morning trade. Potential stocking activity by importers owing to the threat of new...
Copyright 2023-2026 - www.financetom.com All Rights Reserved